The Patent Finder

Kaken Pharmaceutical Co., Ltd.

20 patents currently held · Updated Nov 18, 2026
11 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 6 name spellings.

2
Ending by 2030
Dec 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due May 19, 2027
    The maintenance fee for Applicator (US 10,478,601) comes due May 19, 2027. Unpaid by Nov 19, 2027, it lapses early.
  • 3 fees due Nov 5 to 12, 2027 · next Nov 5

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 20, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US D696,592Vessel including an applicator
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,889,155Gel composition for treating mycosis
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,871,942Process for producing 1-triazole-2-butanol derivatives
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,447,072Pyridone derivative and pharmaceutical containing same
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,000,476Pyridone derivative, pharmaceutical containing the same and methods of use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,518,041(+)-5-(3,4-difluorophenyl)-5-[(3-methyl-2-oxopyridin-1(2H)-yl)methyl]imidazolidine-2,4-dione and drug containing same
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,593,0814-alkynyl imidazole derivative and medicine comprising same as active ingredient
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,855,2574-alkynyl imidazole derivative and medicine comprising same as active ingredient
In force
 · From the USPTO record
In forceFrom the USPTO record
US D880,692Medicine mixing device
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,478,601Applicator
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 20 patents shown.
Pro members see all 20.
Pro members: see all 20 patents
Also on record, not counted in the 20: 11 patents in force now held by others · 29 lapsed for an unpaid fee · 91 ended at full term · 1 past the fee grace period. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 1 abandoned · 10 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited